• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Drug Products
  • All Drug Products
  • QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT

Disease
prostate cancer
Drug Name
Zoladex
Generic Name
goserelin acetate
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Jun 1, 2008
Study Name
NIS-OHU-ZOL/2007/1
Study Id
NIS-OHU-ZOL-2007-1
Recruiting Status
Open
Protocol Status
Not Available
Report
Jun 15, 2011
  • NIS-OHU-ZOL-2007/1.pdf (91 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013